A novel patient-derived xenograft model for claudin-low triple negative breast cancer

BACKGROUND: Triple negative breast cancer (TNBC) subtypes are clinically aggressive and are treated with targeted therapeutics commonly used in other BC subtypes. The claudin-low (CL) molecular subtype of TNBC has high rates of metastases, chemoresistance and recurrence. There exists an urgent need...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Breast Cancer Res Treat
Autors principals: Matossian, Margarite D., Burks, Hope E., Bowles, Annie C., Elliott, Steven, Hoang, Van T., Sabol, Rachel A., Pashos, Nicholas, O’Donnell, Benjamen, Miller, Kristin S., Wahba, Bahia M., Bunnell, Bruce A., Moroz, Krzysztof, Zea, Arnold H., Jones, Steven D., Ochoa, Augusto C., Al-Khami, Amir, Hossain, Fokhrul, Riker, Adam I., Rhodes, Lyndsay V., Martin, Elizabeth C., Miele, Lucio, Burow, Matthew E., Collins-Burow, Bridgette M.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5948145/
https://ncbi.nlm.nih.gov/pubmed/29392581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-018-4685-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars